Drugs that contain Mycophenolate Mofetil Hydrochloride

1. Cellcept patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5543408 ROCHE PALO Crystalline anhydrous mycophenolate mofetil and intravenous formulation thereof
Sep, 2013

(10 years ago)




Market Authorisation Date: 12 August, 1998

Treatment: NA

Dosage: INJECTABLE

More Information on Dosage

CELLCEPT family patents

Family Patents